BRIEF-Valeant CEO Pearson to give deposition to U.S. Senate drug pricing committee - Bloomberg
April 13 (Reuters) -
* Valeant Pharmaceuticals CEO Mike Pearson will give deposition to U.S Senate committee investigating drug pricing, avoiding contempt - Bloomberg
Source - (bloom.bg/1qHMFy9)
Further company coverage: (Reporting by Vishal Sridhar)
© Thomson Reuters 2017 All rights reserved.